The age of RCT's 3 Important Aspects of RCT's in Cardiovascular Pharmacotherapy with examples from Lipid and Diabetes Trials

Authors :: Drexel, Heinz
Rosano, Giuseppe M C
Lewis, Basil S
Huber, Kurt
Vonbank, Alexander
Dopheide, Jörn F.
Mader, Arthur
Niessner, Alexander
Savarese, Gianluigi
Wassmann, Sven
Agewall, Stefan
Source :: Drexel, Heinz; Rosano, Giuseppe M C; Lewis, Basil S; Huber, Kurt; Vonbank, Alexander; Dopheide, Jörn F.; Mader, Arthur; Niessner, Alexander; Savarese, Gianluigi; Wassmann, Sven; Agewall, Stefan (2020). The age of RCT`s 3 Important Aspects of RCT`s in Cardiovascular Pharmacotherapy with examples from Lipid and Diabetes Trials. European heart journal-cardiovascular pharmacotherapy, 6(2), pp. 97-103. Oxford University Press 10.1093/ehjcvp/pvz029
Publication Year :: 2020
Publisher :: Oxford University Press, 2020.

Language :: English
Database :: OpenAIRE
Journal :: Drexel, Heinz; Rosano, Giuseppe M C; Lewis, Basil S; Huber, Kurt; Vonbank, Alexander; Dopheide, Jörn F.; Mader, Arthur; Niessner, Alexander; Savarese, Gianluigi; Wassmann, Sven; Agewall, Stefan (2020). The age of RCT`s 3 Important Aspects of RCT`s in Cardiovascular Pharmacotherapy with examples from Lipid and Diabetes Trials. European heart journal-cardiovascular pharmacotherapy, 6(2), pp. 97-103. Oxford University Press 10.1093/ehjcvp/pvz029 <http://dx.doi.org/10.1093/ehjcvp/pvz029>
Accession number :: edsair.doi.dedup.....2689b4cb9d26e41e436f9e61b5e5ac00
Full Text :: https://doi.org/10.1093/ehjcvp/pvz029

Full Text Access

Tools